Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion (vol 15, pg 531, 1998)

被引：0
|
作者：
Owens, CA
Ambrose, PG
Quintiliani, R
机构：
来源：
CLINICAL DRUG INVESTIGATION | 1998年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 18 条
  • [1] Infusion phlebitis - Relative incidence associated with cefuroxime administered by intermittent and continuous infusion
    Owens, CA
    Ambrose, PG
    Quintiliani, R
    Nightingale, CH
    Nicolau, DP
    CLINICAL DRUG INVESTIGATION, 1998, 15 (06) : 531 - 535
  • [2] Infusion PhlebitisRelative Incidence Associated with Cefuroxime Administered by Intermittent and Continuous Infusion
    Christy A. Owens
    Paul G. Ambrose
    Richard Quintiliani
    Charles H. Nightingale
    David P. Nicolau
    Clinical Drug Investigation, 1998, 15 : 531 - 535
  • [3] RELATIVE INCIDENCE OF PHLEBITIS CAUSED BY CONTINUOUS INTRAVENOUS INFUSION OF CEPHAPIRIN AND CEPHALOTHIN
    LANE, AZ
    TAGGART, JG
    ILES, RL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 2 (03) : 234 - &
  • [4] Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patients (vol 42, pg 1783, 1998)
    Facca, B
    Frame, B
    Triesenberg, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 197 - 197
  • [5] Lung Concentrations of Ceftazidime Administered by Continuous versus Intermittent Infusion in Patients with Ventilator-Associated Pneumonia
    Cousson, Joel
    Floch, Thierry
    Guillard, Thomas
    Vernet, Veronique
    Raclot, Pascal
    Wolak-Thierry, Aurore
    Jolly, Damien
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 1905 - 1909
  • [6] Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
    Lorente, Leonardo
    Jimenez, Alejandro
    Martin, Maria M.
    Iribarren, Jose Luis
    Jose Jimenez, Juan
    Mora, Maria L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (05) : 464 - 468
  • [7] Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors (vol 8, pg 649, 2002)
    Mauser-Bunschoten, EP
    Koopman, MMW
    Goede-Bolder, ADE
    Leebeek, FWG
    van der Meer, J
    Kooij, GMV
    van der Linden, PWG
    HAEMOPHILIA, 2002, 8 (06) : 835 - 835
  • [8] CONTINUOUS INFUSION INTRAVENOUS IMMUNOGLOBULIN IS ASSOCIATED WITH A REDUCED INCIDENCE OF INFECTION AND ACHIEVES HIGHER SERUM IMMUNOGLOBULIN-G LEVELS THAN INTERMITTENT INFUSION FOLLOWING BONE-MARROW TRANSPLANTATION
    SPITZER, TR
    COTTLERFOX, M
    SULLIVAN, P
    LYNCH, M
    TEFFT, MC
    PICKLE, LW
    CIRENZA, E
    CAHILL, R
    DEEG, HJ
    SACHER, R
    SEMINARS IN HEMATOLOGY, 1992, 29 (03) : 123 - 126
  • [9] Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion (vol 13, pg 1768, 1995)
    vanWarmerdam
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 689 - 689
  • [10] Randomised trial of irinotecan fluorouracil by continuous infusion fluorouracil failure in patients with metastatic colorectal cancer (vol 352, pg 1407, 1998)
    Rougier, P
    LANCET, 1998, 352 (9140): : 1634 - 1634
12